November 29 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said on Thursday that its consolidated net profit, excluding interest attributable to minority shareholders in the group's subsidiaries, fell to 30.0 million levs ($17.4 million/15.3 million euro) in the first nine months of the year from 32.7 million levs in the same period of 2017.
about 3 hours agoabout 3 hours agoabout 3 hours agoabout 4 hours ago
about 3 hours agoabout 3 hours agoabout 3 hours agoabout 4 hours agoJun 10, 2026
BucharestJun 30, 2026Marrakech
